EventsPress Release Cortexyme’s Approach to Addressing a Key Underlying Cause of Alzheimer’s Detailed at Alzheimer’s Association International Conference 2019 By admin | Events, Press Release
Press Release Cortexyme Expands Clinical Advisory Board With Key Clinical and Regulatory Experts By admin | Press Release
EventsPress Release Cortexyme to Present at National Academies Forum on Tuesday, June 11, 2019 By admin | Events, Press Release
NewsPress Release Cortexyme Announces Phase 2/3 Clinical Trial Based on Transformational Understanding of Alzheimer’s Disease By admin | News, Press Release
